- CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S.
- New clinical data supporting use of Nanox.ARC to [...] Read more »
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab [...] Read more »
Surplus Solutions Expands Global Offerings with Refurbished Analytical and Medical Equipment, Supported by New Brand and Website Launch
WOONSOCKET, R.I., Feb. 04, 2025 (GLOBE NEWSWIRE) — Surplus Solutions, a global leader in Equipment Lifecycle Management (ELM) services, specializing in procuring and reselling laboratory, processing, and packaging equipment is proud [...] Read more »
SoftSmile and ClearCorrect Announce Settlement
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) — SoftSmile, Inc., ClearCorrect Operating, LLC, and Institut Straumann AG announce that they have amicably settled all litigation and legal disputes between them. The companies [...] Read more »
Publication relating to transparency notifications
Publication relative à des notifications de transparence
INFORMATION RÉGLEMENTÉE
Publication relative à des notifications de transparence
Read more »
Publication relating to transparency notifications
REGULATED INFORMATION
Publication relating to transparency notifications
Read more »
Publication relative à des notifications de transparence
INFORMATION RÉGLEMENTÉE
Publication relative à des notifications de transparence
Read more »
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® en Angleterre
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® en Angleterre
Nyxoah Annonce le Lancement Commercial de la Thérapie [...] Read more »
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
First patients implanted with Genio at UCLH, London
Read more »
Informations sur le nombre total de droits de vote et d'actions
Informations sur le nombre total de droits de vote et d'actions
INFORMATION RÉGLEMENTÉE
Informations [...] Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mont–Saint–Guibert, Belgium – [...] Read more »
Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference
Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference
Nyxoah Participera à la Piper Sandler [...] Read more »
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
REGULATED INFORMATION
November 19, 2024, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »